VOTR Voltatron AG
Voltatron AG provides electronics and electromobility solutions primarily for industrial applications in Germany and internationally. The company engages in the management of patents, licenses, and utility models; distribution of electrical components and customer specific assemblies; and production services, the development, manufacturing, and procure-ment and inventory management of electronic assemblies and devices. It also develops, designs, constructs, distributes, acquires, and operates stationary energy or battery storage systems, including related project development and planning services. In addition, the company offers energy and storage solutions, event and audio technology, industrial electronics, automation and IoT, and medical technology, as well as cosmetics and beauty, and gaming solutions. Further, it provides development and sample production; small, medium and large series production; printed circuit board assembly; assembly and device production; painting and potting; cable assembly and switch cabinet construction; and quality assurance and traceability services. Voltatron AG was formerly known as Voltabox AG and changed its name to Voltatron AG in July 2025. The company was founded in 2011 and is headquartered in Fürth, Germany. Voltatron AG operates as a subsidiary of Trionity Invest GmbH.…
Industry Peers
Auto PartsKey Statistics
About Voltatron (ETR: VOTR)
›
Voltatron (ETR: VOTR) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Auto Parts industry, part of the Consumer Cyclical sector, and reports about 133 employees.
The shares were at 3.250 EUR on 19 November 2026, down 38.2% over 52 weeks. Its 52-week range is 2.850 EUR to 5.540 EUR: the price is 41.3% below the high and 14.0% above the low.
Its market capitalisation is 74.80M EUR.
Voltatron reports return on equity of 143.4%, an operating margin of 2.0% and revenue up 84.3% year over year.
Its debt exceeds its cash by 53.48M EUR. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 4.000 EUR is 23.1% above the current price.